Aperio Group, LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 9 filers reported holding Novozymes A/S in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q1 2014$1,612,000
+26.2%
36,639
+21.3%
0.02%
+15.0%
Q4 2013$1,277,000
+77.6%
30,208
+60.8%
0.02%
+42.9%
Q3 2013$719,000
+36.2%
18,788
+13.8%
0.01%
+7.7%
Q2 2013$528,00016,5150.01%
Other shareholders
Novozymes A/S shareholders Q4 2013
NameSharesValueWeighting ↓
Lenox Wealth Management, Inc. 62,488$2,907,0000.87%
ZEVIN ASSET MANAGEMENT LLC 34,899$1,624,0000.52%
HIGH POINTE CAPITAL MANAGEMENT LLC 5,090$238,0000.33%
BOSTON FINANCIAL MANGEMENT LLC 108,846$5,065,0000.29%
Moloney Securities Asset Management, LLC 15,263$713,0000.24%
Boston Common Asset Management, LLC 24,577$1,148,0000.14%
Hemenway Trust Co LLC 12,125$564,0000.09%
Renaissance Investment Group LLC 5,000$234,0000.09%
QUADRANT CAPITAL GROUP LLC 5,748$263,0000.04%
Douglass Winthrop Advisors, LLC 6,902$321,0000.01%
View complete list of Novozymes A/S shareholders